Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Positive data reported in phase 1/2a studies of therapeutic for pediatric Dravet syndrome
A biotechnology company has announced positive safety and efficacy data from two ongoing phase 1/2a studies as well as an open-label extension study of STK-001 to treat younger individuals with Dravet syndrome.
Q&A: Higher dietary nitrate intake linked to reduced risk for dementia
Higher dietary nitrate intake from vegetables was associated with a reduced risk for dementia, according to research published in the American Journal of Clinical Nutrition.
Log in or Sign up for Free to view tailored content for your specialty!
First-of-its-kind webinar on how doctors should use Threads (or not!)
Less than 1 month since launch, Threads is the new darling of social media platforms. And, you may be unsure if you should be spending your valuable time on the platform to learn, educate or both.
Phase 2 trial of therapeutic for anxiety initiated
A Southern California-based neuroscience company has announced initiation of a phase 2 clinical trial to evaluate the safety and efficacy of investigational therapeutic ENX-102 in those with generalized anxiety disorder.
Firms hope partnership advances access to blood-based Alzheimer’s testing
A partnership between a clinical diagnostics company and a clinical manufacturing firm aims to support therapeutic development, clinical trials, reimbursement and routine clinical adoption for a range of neurodegenerative diseases.
AI-driven medical documentation may help ‘combat the epidemic of burnout’ in neurology
Even before the pandemic, neurologists have been facing issues with burnout and heaping amounts of stress. Meanwhile, the demand for neurologists continues to climb faster than the number of new clinicians in the field.
Probiotics may help slow cognitive decline
BOSTON — Adults with mild cognitive impairment who received the probiotic Lactobacillus rhamnosus GG for 3 months had improvements in cognitive scores compared with those who received placebo, according to findings presented at NUTRITION.
Orphan drug designation sought for stem cell therapy to treat frontotemporal dementia
Therapeutic Solutions International has filed with the FDA to receive orphan drug designation for its JadiCell adult stem cell therapy for treatment of frontotemporal dementia.
Providers support approvals of therapies for prostate cancer, lymphoma, heart disease
An analysis of online conversations among health care professionals on social media in June revealed overwhelming support for FDA approvals of therapies for prostate cancer and lymphoma.
New county-level Alzheimer’s estimates may help allocate resources
New county-level estimates of Alzheimer’s prevalence released at the Alzheimer’s Association International Conference may help inform allocations of funding, staffing and other resources toward caring for patients.
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read